Fig. 2
From: HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer
HOXB2 promotes OV cell growth. A–B. qPCR and WB results showing the knockdown efficiency of HOXB2 in A2780/DDP and OV8 cells. C. Representative images of the EdU incorporation assay. Scale bar, 150 μm. D. Relative cell viability of OV cells transfected with shNC, shHOXB2-1, and shHOXB2-2 lentiviruses. Statistical analyses were performed using a two-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ***P < 0.0001